The incidence of myasthenia gravis: A systematic literature review

Neuroepidemiology

Volumn 34, Issue 3, 2010, Pages 171-183

  McGrogan, Anita ^a   Sneddon, Samantha ^b   De Vries, Corinne S ^a  

^a University of Bath   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Epidemiology; Incidence; Myasthenia gravis; Review literature

Indexed keywords

AGE DISTRIBUTION; EUROPE; HUMAN; INCIDENCE; MYASTHENIA GRAVIS; RELIABILITY; REVIEW; SYSTEMATIC REVIEW;

AGE FACTORS; ANIMALS; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; INCIDENCE; MALE; MYASTHENIA GRAVIS; RISK FACTORS; SEX FACTORS;

EID: 75549086673     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000279334     Document Type: Review

References (45)

1. Thanvi BR, Lo TCN: Update on myasthenia gravis. Postgrad Med J 2004; 80: 690-700.
2. Juel VC, Massey JM: Myasthenia gravis. Orphanet J Rare Dis 2007; 2: 44.
3. Hohlfeld R, Wekerle H: The immunopathogenesis of myasthenia gravis; in Engel AG (ed): Myasthenia Gravis and Myasthenic Disorders, ed 1. Oxford, Oxford University Press, 1999, pp 87-110.
4. Vincent A, Palace J, Hilton-Jones D: Myasthenia gravis. Lancet 2001; 357: 2122-2128. (Pubitemid 32607461)
5. Lindstrom J, Shelton D, Fujii Y: Myasthenia gravis. Adv Immunol 1988; 42: 233.
6. Osserman KE, Genkins G: Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients. Mount Sinai J Med 1972; 38: 497-537.
7. Engel AG: Acquired autoimmune myasthenia gravis; in Engel AG, Banker BQ (eds). Myology: Basic and Clinical. New York, Mc- Graw-Hill, 1986, pp 1925-1954.
8. Chiang LM, Darras BT, Kang PB: Juvenile myasthenia gravis. Muscle Nerve 2009; 39: 423-431.
9. Hilton-Jones D, Palace J: Disorders of the neuromuscular junction; in Warrell DA, Cox TM, Firth JD, Benz EJ (eds): Oxford Textbook of Medicine, ed 4. Oxford, Oxford University Press, 2003, pp 1167-1172.
10. Sanders DB, El-Salem K, Massey JM, Mc- Conville J, Vincent A: Clinical aspects of MuSK antibody positive seronegative MG. Neurology 2003; 60: 1978-1980. (Pubitemid 36736017)
11. Riedel RF, Burfeind WR: Thymoma: benign appearance, malignant potential. Oncologist 2006; 11: 887-894.
12. Materljan E: Epidemiology of neuroimmune diseases. Acta Clin Croat Suppl 1997; 36: 60-61. (Pubitemid 29162219)
13. Somnier FE, Engel PJH: The occurrence of anti-titin antibodies and thymomas: a population survey of myasthenia gravis, 1970- 1999. Neurology 2002; 59: 92-98.
14. MacDonald BK, Cockerell OC, Sander JW, et al: The incidence and lifetime prevalence of neurological disorders in a prospective community- based study in the UK. Brain 2000; 123: 685-1676
15. Vincent A, Clover L, Buckley C, Grimley EJ, Rothwell PM, UK Myasthenia GS: Evidence of underdiagnosis of myasthenia gravis in older people. J Neurol Neurosurg Psychiatry 2003; 74: 1105-1108. (Pubitemid 36936389)
16. Storm-Mathisen A: Epidemiology of myasthenia gravis in Norway. Acta Neurol Scand 1984; 70: 274-284. (Pubitemid 14018371)
17. Christensen PB, Jensen TS, Tsiropoulos I, Sorensen T, Kjaer M, Hojer-Pedersen E, et al: Incidence and prevalence of myasthenia gravis in western Denmark: 1975 to 1989. Neurology 1993; 43: 1779-1783. (Pubitemid 23307954)
18. Wirtz PW, Nijnuis MG, Sotodeh M, Willems LN, Brahim JJ, Putter H, et al: The epidemiology of myasthenia gravis, Lambert-Eaton myasthenic syndrome and their associated tumours in the northern part of the province of South Holland. J Neurol 2003; 250: 698-701. (Pubitemid 36718358)
19. Guidetti D, Sabadini R, Bondavalli M, Cavalletti S, Lodesani M, Mantegazza R, et al: Epidemiological study of myasthenia gravis in the province of Reggio Emilia, Italy. Eur J Epidemiology 1998; 14: 381-387. (Pubitemid 28288462)
20. Oopik M, Kaasik AE, Jakobsen J: A population- based epidemiological study on myasthenia gravis in Estonia. J Neurol Neurosurg Psychiatry 2003; 74: 1638-1643. (Pubitemid 37542051)
21. Lavrnic D, Jarebinski M, Rakocevic-Stojanovic V, Stevic Z, Lavrnic S, Pavlovic S, et al: Epidemiological and clinical characteristics of myasthenia gravis in Belgrade, Yugoslavia (1983-1992). Acta Neurol Scand 1999; 100: 168-174. (Pubitemid 29376828)
22. Zivadinov R, Jurjevic A, Willheim K, Cazzato G, Zorzon M: Incidence and prevalence of myasthenia gravis in the county of the coast and Gorski kotar, Croatia, 1976 through 1996. Neuroepidemiology 1998; 17: 265-272. (Pubitemid 28394102)
23. Casetta I, Fallica E, Govoni V, Azzini C, Tola M, Granieri E: Incidence of myasthenia gravis in the province of Ferrara: a communitybased study. Neuroepidemiology 2004; 23: 281-284. (Pubitemid 39279478)
24. Aragones JM, Bolibar I, Bonfill X, Bufill E, Mummany A, Alonso F, et al: Myasthenia gravis: a higher than expected incidence in the elderly. Neurology 2003; 60: 1024-1026. (Pubitemid 36355833)
25. Radhakrishnan K, Thacker AK, Maloo JC, Gerryo SE, Mousa ME: Descriptive epidemiology of some rare neurological diseases in Benghazi, Libya. Neuroepidemiology 1988; 7: 159-164.
26. Giagheddu M, Puggioni G, Sanna G, Tamburini G, Marrosu F, Rachele MG, et al: Epidemiological study of myasthenia gravis in Sardinia, Italy (1958-1986). Acta Neurol Scand 1989; 79: 326-333. (Pubitemid 19115293)
27. Aiello I, Pastorino M, Sotgiu S, Pirastru MI, Sau GF, Sanna G, et al: Epidemiology of myasthenia gravis in northwestern Sardinia. Neuroepidemiology 1997; 16: 199-206. (Pubitemid 27320744)
28. Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology: Incidence of myasthenia gravis in the Emilia-Romagna region: a prospective multicenter study. Neurology 1998; 51: 255-258.
29. Ferrari G, Lovaste MG: Epidemiology of myasthenia gravis in the province of Trento (northern Italy). Neuroepidemiology 1992; 11: 135-142.
30. Somnier FE, Keiding N, Paulson OB: Epidemiology of myasthenia gravis in Denmark: a longitudinal and comprehensive population survey. Arch Neurol 1991; 48: 733-739.
31. Oosterhuis HJ: The natural course of myasthenia gravis: a long-term follow-up study. J Neurol Neurosurg Psychiatry 1989; 52: 1121-1127.
32. Yu YL, Hawkins BR, Ip MS, Wong V, Woo E: Myasthenia gravis in Hong Kong Chinese. 1. Epidemiology and adult disease. Acta Neurol Scand 1992; 86: 113-119.
33. Matsuda M, Dohi-Iijima N, Nakamura A, Sekijima Y, Morita H, Matsuzawa S, et al: Increase in incidence of elderly-onset patients with myasthenia gravis in Nagano Prefecture, Japan. Intern Med 2005; 44: 572-577. (Pubitemid 40932830)
34. Angelini C, Micaglio GF, Sartori V, Riviera MP, Ferarri G, Fincati E, et al: Epidemiology of myasthenia gravis in a north-east area of Italy. J Autoimmun 1991; 4:xvii-243.
35. Cisneros AD, Luis RS, Leon R, Carrera PL: Algunos aspectos epidemiológicos de la miastenia gravis en Cuba. Rev Neurol 1996; 24: 435-439.
36. Robertson NP, Deans J, Compston DA: Myasthenia gravis: a population-based epidemiological study in Cambridgeshire, England. J Neurol Neurosurg Psychiatry 1998; 65: 492-496. (Pubitemid 28438878)
37. Schon F, Drayson M, Thompson RA: Myasthenia gravis and elderly people. Age Ageing 1996; 25: 56-58. (Pubitemid 26036228)
38. Farrugia ME: A limited epidemiological study of seropositive myasthenia gravis in Tayside. Scott Med J 2002; 47: 132-135.
39. Matuja WB, Aris EA, Gabone J, Mgaya EM: Incidence and characteristics of myasthenia gravis in Dar Es Salaam, Tanzania. East Afr Med J 2001; 78: 473-476. (Pubitemid 33727576)
40. Poulas K, Tsibri E, Kokla A, Papanastasiou D, Tsouloufis T, Marinou M, et al: Epidemiology of seropositive myasthenia gravis in Greece. J Neurol Neurosurg Psychiatry 2001; 71: 352-356. (Pubitemid 32772533)
41. Sorensen TT, Holm EB: Myasthenia gravis in the county of Viborg, Denmark. Eur Neurol 1989; 29: 177-179.
42. Holtsema H, Mourik J, Rico RE, Falconi JR, Kuks JB, Oosterhuis HJ: Myasthenia gravis on the Dutch Antilles: an epidemiological study. Clin Neurol Neurosurg 2000; 102: 195-198. (Pubitemid 32012613)
43. Phillips LH, Torner JC, Anderson MS, Cox GM: The epidemiology of myasthenia gravis in central and western Virginia. Neurology 1992; 42: 1888-1893.
44. McGrogan A, Seaman HE, Wright JW, de Vries CS: The incidence of autoimmune thyroid disease: a systematic review of the literature. Clin Endocrinol 2008; 69: 687-696.
45. McGrogan A, Madle GC, Seaman HE, de Vries CS: The epidemiology of Guillain-Barré Syndrome worldwide. Neuroepidemiology 2009; 32: 150-163.